MétaCan
Menu
← Back to cohort
Record W4416407061 · doi:10.1093/cid/ciaf635

Risk of Hepatocellular Carcinoma After Direct-Acting Antiviral Treatment for Hepatitis C Virus Infection in People With HIV

2025· article· en· W4416407061 on OpenAlexaff
Daniela K van Santen, Mathieu Chalouni, Juan Berenguer, Inmaculada Jarrín, José M. Miró, Marina B. Klein, Jim Young, Jessie Torgersen, Christopher T. Rentsch, M. John Gill, Rachel Epstein, David Nunes, Bernard Surial, Andri Rauch, Giota Touloumi, Antonios Papadopoulos, Linda Wittkop, Camille Gilbert, Olivier Leleux, Marc van der Valk, Anders Boyd, Antonella d'Arminio Monforte, Massimo Puoti, Robert Zangerle, Martin Gisinger, Roger Logan, Sophia M. Rein, Miguel A. Hernán, Sara Lodi

Bibliographic record

VenueClinical Infectious Diseases · 2025
Typearticle
Languageen
FieldMedicine
TopicHepatitis C virus research
Canadian institutionsInstitute of Infection and ImmunityMcGill UniversityAlberta Hip and Knee ClinicUniversity of CalgaryMcGill University Health Centre
FundersNational Institute of Allergy and Infectious DiseasesAgence Nationale de Recherches sur le Sida et les Hépatites ViralesNational Institute on Drug AbuseCenter for AIDS Research, University of WashingtonNational Institutes of HealthPatrick and Catherine Weldon Donaghue Medical Research Foundation
KeywordsHepatocellular carcinomaHepatitis C virusCirrhosisHuman immunodeficiency virus (HIV)Hepatitis CHepacivirusViral diseaseFibrosis

Abstract

fetched live from OpenAlex

BACKGROUND: To inform hepatocellular carcinoma (HCC) surveillance after hepatitis C virus (HCV) cure with direct-acting antivirals (DAA), we estimated HCC risk post-DAA in people with human immunodeficiency virus (HIV) with advanced liver fibrosis or cirrhosis under universal DAA. METHODS: We used data from HepCAUSAL, a collaboration of cohorts of HIV-HCV coinfection from Europe and North America. Eligibility criteria were HIV-HCV coinfection, advanced liver fibrosis or cirrhosis, DAA naïve, HIV-RNA < 50 copies/mL, on antiretroviral therapy, no HBV coinfection, and no prior HCC diagnosis or liver transplant. Follow-up started when eligibility was met and ended at HCC diagnosis, death, loss to follow-up, 6 years, or database closure, whichever came first. We estimated the 6-year risk and annual probability of HCC if all eligible individuals had initiated DAA at baseline using a weighted pooled logistic model for the monthly HCC risk among DAA initiators. RESULTS: Of 3824 eligible individuals (92% males, median age 60 years [IQR: 54, 64]), 2373 (62%) who initiated DAA, 43 had an HCC diagnosis during follow-up. The estimated 6-year HCC risk (95% CI) under universal DAA was 2.5% (1.6, 3.9). Annual HCC probability was 0.81% (0.34, 1.54) between baseline and month 12 after DAA initiation, 0.64% (0.28, 1.19) between years 1 and 2, 0.50% (0.27, 0.84) between years 2 and 3, 0.34% (0.13, 0.63) between years 3 and 4, 0.19% (0.07, 0.33) between years 4 and 5, and 0.10% (0.01, 0.24) between years 5 and 6. CONCLUSIONS: An estimated 2.5% of people with HIV and advanced liver fibrosis or cirrhosis are diagnosed with HCC by 6 years post-DAA. Annual probability of HCC declines over time and falls below 0.4% after 3 years.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.005
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.008
Threshold uncertainty score0.017

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.005
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.031
GPT teacher head0.362
Teacher spread0.331 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueClinical Infectious Diseases→Same topicHepatitis C virus research→French-language works237,207→